Shandling A H, Crump R, Nolasco M, Lorenz L M, Li C K
Memorial Heart Institute, Long Beach Memorial Medical Center, CA 90801-1428.
Clin Cardiol. 1992 Dec;15(12):917-22. doi: 10.1002/clc.4960151212.
Chronic overdrive suppression pacing has been suggested as an effective adjunctive method for reducing the incidence of cardiac tachyarrhythmias. Documentation of effectiveness during prolonged monitoring is lacking, however. To assess more accurately the long-term utility of this treatment modality for medically refractory supraventricular tachyarrhythmias (SVTs), 10 patients with atrially implanted Intermedics Intertach pacemakers were randomly assigned to either a low or a high bradycardia (back-up) pacing rate. SVT counts were performed during matching follow-up periods both at the initial rate and after rate crossover. The primary antitachycardia modality of this pacemaker (P mod) provides burst pacing to terminate tachycardia episodes, and P mod counters were utilized to quantitate SVT episodes. Tachycardia termination algorithms were programmed to "no restart" and were not changed during the study. The P mod use counter, therefore, reflected the number of discrete episodes of SVTs. Pacemaker implantation diagnoses include atrial flutter, concealed bypass tract, AV nodal reentry, intraatrial reentry, and Wolff-Parkinson-White associated tachycardia. Patient age was 59 +/- 18 yrs. The average pacemaker back-up low rate was 45.7 +/- 4 versus a back-up high rate of 85.1 +/- 2 beats/min. Follow-up was for 57.4 days +/- 33 days at the low rate and 57.3 days +/- 34 days at the high rate (r = 0.99). There was no difference in SVT incidence with a P mod usage of 98.4 +/- 106 at the low rate and 100.8 +/- 94 at the high rate (p = NS). In this blinded, randomized cross-over trial, chronic atrial overdrive suppression pacing did not reduce the overall incidence of SVT episodes during prolonged monitoring.
慢性超速抑制起搏已被认为是一种有效的辅助方法,可降低心脏快速性心律失常的发生率。然而,缺乏长期监测期间有效性的记录。为了更准确地评估这种治疗方式对药物难治性室上性快速性心律失常(SVT)的长期效用,10例植入Intermedics Intertach心房起搏器的患者被随机分配到低或高的心动过缓(备用)起搏频率组。在初始频率以及频率交叉后,在匹配的随访期内进行SVT计数。该起搏器的主要抗心动过速模式(P模式)提供短阵快速起搏以终止心动过速发作,并使用P模式计数器对SVT发作进行定量。心动过速终止算法被编程为“不重启”,并且在研究期间未改变。因此,P模式使用计数器反映了SVT离散发作的次数。起搏器植入诊断包括心房扑动、隐匿性旁路、房室结折返、房内折返以及与预激综合征相关的心动过速。患者年龄为59±18岁。起搏器备用低频率平均为45.7±4次/分钟,而备用高频率为85.1±2次/分钟。低频率组随访57.4天±33天,高频率组随访57.3天±34天(r = 0.99)。低频率组P模式使用次数为98.4±106,高频率组为100.8±94,SVT发生率无差异(p =无显著性差异)。在这项双盲、随机交叉试验中,慢性心房超速抑制起搏在长期监测期间并未降低SVT发作的总体发生率。